Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
BackgroundCinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk of hypocalcemia, increased QT interval and drug interactions. In this study, we report the French experience in...
Saved in:
Main Authors: | Julie Bernardor (Author), Sacha Flammier (Author), Jean-Pierre Salles (Author), Cyril Amouroux (Author), Mireille Castanet (Author), Anne Lienhardt (Author), Laetitia Martinerie (Author), Ivan Damgov (Author), Agnès Linglart (Author), Justine Bacchetta (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intermittent Bi-Daily Sub-cutaneous Teriparatide Administration in Children With Hypoparathyroidism: A Single-Center Experience
by: Julie Bernardor, et al.
Published: (2021) -
Case Report, Practices Survey and Literature Review of an Under-Recognized Pediatric Vascular Disorder: The BASCULE Syndrome
by: Natacha Baurens, et al.
Published: (2022) -
Circulating autotaxin levels in healthy teenagers: Data from the Vitados cohort
by: Marie-Noëlle Méaux, et al.
Published: (2023) -
Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension
by: Béatrice Bouhanick, et al.
Published: (2021) -
Editorial: IPEX 2020: An Expanding Disease Spectrum and Novel Precision Therapies
by: Rosa Bacchetta, et al.
Published: (2022)